Proteome Sciences Plc (PRM.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 323 | -355 | -57 | -19 | -1 |
| Other Working Capital | -1,324 | 441 | -152 | 491 | 518 |
| Other Operating Activity | 5,004 | -3,057 | -3,913 | -4,565 | -4,123 |
| Operating Cash Flow | $4,003 | $-2,971 | $-4,122 | $-4,093 | $-3,606 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -631 | -11 | -31 | -23 | -357 |
| Other Investing Activity | 14 | 1 | 9 | 10 | 45 |
| Investing Cash Flow | $-617 | $-10 | $-22 | $-13 | $-312 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -5,454 | 2,699 | 3,151 | 4,302 | 1,634 |
| Common Stock Issued | 11,516 | N/A | 523 | N/A | 5 |
| Financing Cash Flow | $6,062 | $2,699 | $3,674 | $4,302 | $1,639 |
| Exchange Rate Effect | -35 | 139 | 213 | 30 | -4 |
| Beginning Cash Position | 131 | 274 | 530 | 304 | 2,587 |
| End Cash Position | 9,544 | 131 | 273 | 530 | 304 |
| Net Cash Flow | $9,448 | $-282 | $-470 | $196 | $-2,279 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,003 | -2,971 | -4,122 | -4,093 | -3,606 |
| Capital Expenditure | -631 | -11 | -31 | -23 | -357 |
| Free Cash Flow | 3,372 | -2,982 | -4,153 | -4,116 | -3,963 |